Genetic deletion of JNK1 and JNK2 aggravates the DSS-induced colitis in mice

Journal of Investigative Surgery

Volumn 20, Issue 1, 2007, Pages 23-33

  Chromik, A M ^a   Muller A M ^b   Korner J ^a   Belyaev, O ^a   Holland Letz, T ^c   Schmitz, F ^a   Herdegen, T ^d   Uhl, W ^a   Mittelkotter U ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE 9; STRESS ACTIVATED PROTEIN KINASE 1;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; DISEASE ACTIVITY; DISEASE SEVERITY; GENE DELETION; GENE EXPRESSION REGULATION; GENOTYPE; HEMATOCHEZIA; KNOCKOUT MOUSE; MORTALITY; MOUSE; NONHUMAN; OCCULT BLOOD TEST; PRIORITY JOURNAL; TRANSGENIC MOUSE; WEIGHT REDUCTION; WILD TYPE; ANIMAL; APOPTOSIS; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; COMPARATIVE STUDY; CROSS BREEDING; ENZYMOLOGY; GASTROINTESTINAL HEMORRHAGE; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; PATHOLOGY; PHYSIOLOGY; SINGLE BLIND PROCEDURE;

ANIMALS; APOPTOSIS; CHRONIC DISEASE; COLITIS; CROSSES, GENETIC; DEXTRAN SULFATE; GASTROINTESTINAL HEMORRHAGE; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; SINGLE-BLIND METHOD; WEIGHT LOSS;

EID: 34247847785     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.1080/08941930601126140     Document Type: Article

References (49)

1. van Montfrans, C., Peppelenbosch, M., Velde, A A te and van Deventer, S. (2002) Inflammatory signal transduction in Crohn's disease and novel therapeutic approaches. Biochem Pharmacol, 64:5, pp. 789-795.
2. Rogler, G. (2004) Update in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol., 20:4, pp. 311-317.
3. Dong, C., Davis, R. J. and Flavell, R. A. (2002) MAP kinases in the immune response. Annu Rev Immunol., 20, pp. 55-72.
4. Kyriakis, J. M. and Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev., 81:2, pp. 807-869.
5. Davis, R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell., 103:2, pp. 239-252.
6. Karin, M. (1998) Mitogen-activated protein kinase cascades as regulators of stress responses. Ann NY Acad Sci., 851, pp. 139-146.
7. Hommes, D. W., Peppelenbosch, M. P. and van Deventer, S. J. (2003) Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut., 52:1, pp. 144-151.
8. Gupta, S., Barrett, T. and Whitmarsh, A. J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J., 15:11, pp. 2760-2770.
9. Waetzig, G. H., Seegert, D., Rosenstiel, P., Nikolaus, S. and Schreiber, S. (2002) p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol., 168:10, pp. 5342-5351.
10. Hommes, D., Blink, B van den and Plasse, T. (2002) Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology., 122:1, pp. 7-14.
11. Ip, Y. T. and Davis, R. J. (1998) Signal transduction by the c-Jun N-terminal kinase (JNK) - From inflammation to development. Curr Opin Cell Biol., 10:2, pp. 205-219.
12. Shaulian, E. and Karin, M. (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol., 4:5, p. E131.
13. Jang, B. C., Paik, J. H. and Kim, S. P. (2005) Catalase induced expression of inflammatory mediators via activation of NF-kappaB, PI3K/ AKT, p70S6K, and JNKs in BV2 microglia. Cell Signal., 17:5, pp. 625-633.
14. Waetzig, V., Czeloth, K. and Hidding, U. (2005) c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia., 50:3, pp. 235-246.
15. Rincon, M. and Pedraza-Alva, G. (2003) JNK and p38 MAP kinases in CD4+ and CD8+ T cells. Immunol Rev., 192, pp. 131-142.
16. Dong, C., Davis, R. J. and Flavell, R. A. (2001) Signaling by the JNK group of MAP kinases. c-jun N-terminal Kinase. J Clin Immunol., 21:4, pp. 253-257.
17. Yang, D. D., Conze, D. and Whitmarsh, A. J. (1998) Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity., 9:4, pp. 575-585.
18. Dong, C., Yang, D. D., Wysk, M., Whitmarsh, A. J., Davis, R. J. and Flavell, R. A. (1998) Defective T cell differentiation in the absence of Jnk1. Science, 282:5396, pp. 2092-2095.
19. Manning, A. M. and Davis, R. J. (2003) Targeting J NK for therapeutic benefit: From junk to gold. Nat Rev Drug Discov., 2:7, pp. 554-565.
20. Kontoyiannis, D., Boulougouris, G. and Manoloukos, M. (2002) Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J Exp Med., 196:12, pp. 1563-1574.
21. Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F. and Kollias, G. (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies. Immunity, 10:3, pp. 387-398.
22. Cooper, H. S., Murthy, S. N., Shah, R. S. and Sedergran, D. J. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest., 69:2, pp. 238-249.
23. Murthy, S. N., Cooper, H. S., Shim, H., Shah, R. S., Ibrahim, S. A. and Sedergran, D. J. (1993) Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci., 38:9, pp. 1722-1734.
24. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y. and Nakaya, R. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology., 98:3, pp. 694-702.
25. Strober, W., Fuss, I. J. and Blumberg, R. S. (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol., 20, pp. 495-549.
26. Melgar, S., Karlsson, A. and Michaelsson, E. (2005) Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: Correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol., 288:6, p. G1328.
27. Brecht, S., Kirchhof, R. and Chromik, A. (2005) Specific pathophysiological functions of JNK isoforms in the brain. Eur J Neurosci., 21:2, pp. 363-377.
28. Wolfer, D. P., Crusio, W. E. and Lipp, H. P. (2002) Knockout mice: Simple solutions to the problems of genetic background and flanking genes. Trends Neurosci., 25:7, pp. 336-340.
29. Kuan, C. Y., Yang, D. D., Roy, D R Samanta, Davis, R. J., Rakic, P. and Flavell, R. A. (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron., 22:4, pp. 667-676.
30. Egger, B., Procaccino, F. and Lakshmanan, J. (1997) Mice lacking transforming growth factor alpha have an increased susceptibility to dextran sulfate-induced colitis. Gastroenterology., 113:3, pp. 825-832.
31. Winzen, R., Kracht, M. and Ritter, B. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J., 18:18, pp. 4969-4980.
32. Ming, X. F., Stoecklin, G., Looser, R. and Moroni, C. (2001) Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Mol Cell Biol., 21:17, pp. 5778-5789.
33. Lee, J. C., Kassis, S., Kumar, S., Badger, A. and Adams, J. L. (1999) p38 mitogen-activated protein kinase inhibitors - Mechanisms and therapeutic potentials. Pharmacol Ther., 82:2, pp. 389-397.
34. Hollenbach, E., Neumann, M., Vieth, M., Roessner, A., Malfertheiner, P. and Naumann, M. (2004) Inhibition of p38 MAP kinase- and RICK/ NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB J., 18:13, pp. 1550-1552.
35. Hollenbach, E., Vieth, M., Roessner, A., Neumann, M., Malfertheiner, P. and Naumann, M. (2005) Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. J Biol Chem., 280:15, pp. 14981-14988.
36. Kaiser, R. A., Liang, Q. and Bueno, O. F. (2005) Genetic inhibition or activation of JNK1/2 each protect the myocardium from ischemia-reperfusion-induced cell death in vivo. J Biol Chem., 280:38, pp. 32602-32608.
37. Dietrich, N., Thastrup, J. and Holmberg, C. (2004) JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways. Cell Death Differ., 11:3, pp. 301-313.
38. Mielke, K. and Herdegen, T. (2000) JNK and p38 stresskinases - Degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol., 61:1, pp. 45-60.
39. Lei, K. and Davis, R. J. (2003) JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA., 100:5, pp. 2432-2437.
40. Tsuruta, F., Sunayama, J. and Mori, Y. (2004) JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J., 23:8, pp. 1889-1899.
41. Eminel, S., Klettner, A., Roemer, L., Herdegen, T. and Waetzig, V. (2004) JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine. J Biol Chem., 279:53, pp. 55385-55392.
42. Sabapathy, K. and Kallunki, T. (1999) JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr Biol., 9:3, pp. 116-125.
43. Hidding, U., Mielke, K. and Waetzig, V. (2002) The c-Jun N-terminal kinases in cerebral microglia: Immunological functions in the brain. Biochem Pharmacol., 64:5, pp. 781-788.
44. Mudter, J. and Neurath, M. F. (2003) Mucosal T cells: Mediators or guardians of inflammatory bowel disease. Curr Opin Gastroenterol., 19:4, pp. 343-349.
45. Atreya, R., Mudter, J. and Finotto, S. (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in crohn disease and experimental colitis in vivo. Nat Med., 6:5, pp. 583-588.
46. Sanna, M. G., Duckett, C. S., Richter, B. W., Thompson, C. B. and Ulevitch, R. J. (1998) Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc Natl Acad Sci USA., 95:11, pp. 6015-6020.
47. Sanna, M. G., Correia, J da Silva and Ducrey, O. (2002) IAP suppression of apoptosis involves distinct mechanisms: The TAK1/JNK1 signaling cascade and caspase inhibition. Mol Cell Biol., 22:6, pp. 1754-1766.
48. Boutros, M., Agaisse, H. and Perrimon, N. (2002) Sequential activation of signaling pathways during innate immune responses in Drosophila. Dev Cell., 3:5, pp. 711-722.
49. Wajant, H. and Scheurich, P. (2004) Analogies between Drosophila and mammalian TRAF pathways. Prog Mol Subcell Biol., 34, pp. 47-72.